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A b s t r a c t
Background: Cardiovascular diseases are the main cause of morbidity and an important cause of disability and premature 
death in European countries. Current guidelines recommend prevention delivery by physicians during medical consultations.
Aim: We sought to evaluate the prevention support offered by Polish physicians in 2013–2014 compared to 2003–2005, 
and its determinants.
Methods: The data from two population surveys were analysed: WOBASZ (6392 men and 7153 women, aged 20–74 years, 
screened in 2003–2005) and WOBASZ II (2751 men and 3418 women, aged ≥ 20 years, screened in 2013–2014). For com-
parison analysis, the population of WOBASZ II was restricted to persons aged 20–74 years. Prevention delivery was assessed 
using a questionnaire. 
Results: Overall, 64% of men and 75% of women screened in 2003–2005 consulted their physicians at least once in the 
preceding year; 10 years later these rates were 70% and 82%, respectively. In both studies, 70% of respondents recalled 
having received one piece of prevention advice during a medical consultation. One-third of participants neither received 
any prevention advice nor had their blood pressure or cholesterol level measured. In WOBASZ II we observed a significant 
increase in the frequency of counselling regarding smoking cessation, nutrition, and increased physical activity, as well as in 
the frequency of cholesterol measurements, compared to WOBASZ. The prevention support was related to the health status. 
Conclusions: The prevention support in the years 2013–2014 was better than in 2003–2005, but was still insufficient. About 
one-third of participants did not receive any preventive advice. The prevention support was offered more often to patients 
with worse health status. 
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INTRODUCTION
Cardiovascular diseases (CVDs), especially coronary artery 
disease (CAD), are the main cause of morbidity and an im-
portant cause of disability and premature death in European 
countries, irrespective of the systematic decrease in CVD 
deaths both in Europe [1] and in Poland [2]. CVD preven-
tion at the individual and population levels is one of the 
main challenges for medical staff and politicians. CVDs are 
strongly associated with an unhealthy lifestyle, particularly 
with smoking, an unhealthy diet, low level of physical activ-
ity, and psychological stress [3]. Analysis using the IMPACT 
model showed that a decrease in CAD mortality was associ-
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ated with positive changes in lifestyle by more than 50% [4]. 
In the INTERHEART study, it was found that nine modifiable 
risk factors (smoking, hypertension, diabetes, abnormal lipid 
levels, dietary habits, alcohol consumption, abdominal obesity, 
low level of physical activity, and psychosocial factors) were 
responsible for 90% of the risk of myocardial infarction [5]. 
Preventive guidelines highlighted the necessity of promoting 
a healthy lifestyle and early identification of patients with 
high cardiovascular (CV) risk by all health professionals [1]. 
Professional support is needed in smoking cessation, adoption 
of a healthy diet, and increasing physical activity [1]. Health 
care systems are mainly dominated by acute care, medical 
technology, and pharmacological treatment, while lifestyle 
modification is judged as a personal matter [6].
The aim of the study was to evaluate the prevention 
counselling in Poland in the years 2013–2014 compared to 
2003–2005, and its determinants. 
METHODS
Study population and methods of sample drawing
As part of the Multi-centre National Population Health 
Examination Survey, WOBASZ (2003–2005), 6392 men and 
7153 women, aged 20–74 years were screened. WOBASZ II 
study (2013–2014) included 2751 men and 3418 women, 
aged ≥ 20 years. Sample drawing (from the electronic register 
— PESEL database) had three stages and was stratified accord-
ing to voivodship, type of commune, and gender. For each 
voivodship, two small, two medium, and two large communes 
were selected. WOBASZ II covered the same communes as 
those participating in the WOBASZ study, however the sample 
of individuals drawn in each commune was independent. The 
aims and methods of the WOBASZ and WOBASZ II studies 
have been described previously [7–9]. Both studies were ac-
cepted by the Local Ethics Committee, and all respondents 
gave written, informed consent to participate. The examina-
tion was conducted by trained nurses or interviewers, and 
several quality evaluations were performed by supervisors 
from the coordinating centre.
The following groups of participants were selected: 
persons subjected to secondary prevention (with diagnosed 
CAD or a history of stroke), persons subjected to primary 
prevention (with high CV risk defined as the presence of 
CVD risk factors: smoking, diabetes, hypertension, and lipid 
disorders, but without diagnosed CAD or a history of stroke), 
and persons without CVD risk factors. 
Hypertensive persons were defined as those with arterial 
blood pressure ≥ 140/90 mmHg (the mean from the second 
and third measurements) or on antihypertensive treatment. 
Hypercholesterolaemia was defined as total cholesterol 
level ≥ 5.0 mmol/L or low-density lipoprotein-cholesterol 
level ≥ 3.0 mmol/L or triglyceride level ≥ 1.7 mmol/L or 
the presence of hypolipemic treatment. Participants who 
regularly smoked at least one cigarette per day were classi-
fied as persons with a smoking habit. Subjects with glucose 
concentration ≥ 7.0 mmol/L or on hypoglycaemic treatment 
were classified as diabetic.
Evaluation of preventive action 
Preventive action was evaluated based on a questionnaire gather-
ing information on the frequency of lifestyle modification advice 
offered during medical consultation (recommendations regarding 
proper nutrition, increase in physical activity and smoking cessa-
tion — in the case of active smokers) as well as the frequency of 
blood pressure measurement and blood cholesterol concentra-
tion measurement performed within the preceding year.
Statistical analysis
All analyses were done separately for men and women. 
For comparison of frequencies of preventive counselling in 
particular groups and between the two studies, the model 
of analysis of covariance with adjustment for age was used 
(populations of WOBASZ and WOBASZ II differed signifi-
cantly in terms of the mean age of study participants), and 
the results were shown as frequencies with confidence 
intervals. To evaluate the contribution of particular types of 
medical practice in medical consultations and in preventive 
counselling, we took into account only persons who gave 
a single answer to the question about the most frequently 
consulted medical practitioner (consequently, 694 persons 
from WOBASZ and 656 persons from WOBASZ II, who 
gave more than one answer, were not included into these 
analyses). For the assessment of the relationship between 
preventive support and selected factors multivariate logistic 
regression was used. The level of statistical significance was 
set at p < 0.05. The analyses were done using SAS software 
version 9.2 (SAS Institute, Inc., Cary, NY, USA).
RESULTS
Overall, 63.8% of men and 75.3% of women in the WOBASZ 
study visited their physician at least once a year. In WOBASZ II, 
these rates were slightly higher (75.3% of men, 81.5% of 
women) (Table 1). In both study periods, the most frequently 
consulted doctor was a general practitioner (GP) (more than 
80% of cases), and private specialist practices were visited the 
least often. The proportion of medical practice types in medi-
cal consultations did not differ between the studies, except 
for men in WOBASZ II, who consulted private specialist prac-
tioners more often compared to men in WOBASZ (Table 2). 
In the analysis of the preventive action according to the 
type of medical practice, we found a significant increase in 
the frequency of preventive counselling between the years 
2003–2005 and 2013–2014 only for GPs; the percentage of 
at least two preventive consultations during one medical visit 
increased from 36.6% to 45.5% in men and from 35.3% to 
41.2% in women, respectively (Table 3). Additionally, both in 
WOBASZ and WOBASZ II, the best preventive support (the 
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Table 1. Prevention support in the general population in Poland based on the results of the WOBASZ and WOBASZ II studies 
(adjusted for age)
WOBASZ — % (95% CI) WOBASZ II — % (95% CI)
Men
Blood pressure measurement* 55.7 (58.4–60.9) 60.1 (57.9–62.2)
Dietary consultation* 24.9 (23.7–26.2) 31.9 (29.9–34.0)
Smoking cessation consultation* 52.1 (50.2–53.8) 57.5 (53.9–61.0)
Physical activity counselling* 18.2 (17.1–19.3) 26.6 (24.3–28.5)
Cholesterol measurement (within previous year) 22.8 (21.6–24.0) 57.8 (55.3–60.3) 
Prevention delivery (at least one of the above-mentioned) 68.5 (67.5–69.5) 68.3 (66.7–70.0)
Medical consultation (within previous year) 63.8 (62.7–64.9) 69.6 (67.8–71.4)
Women
Blood pressure measurement* 64.7 (63.5–65.9) 60.1 (58.2–62.1) 
Dietary consultation* 27.9 (26.7–29.1) 29.4 (27.5–31.3) 
Smoking cessation consultation* 48.4 (46.1–50.7) 53.0 (49.1–56.9)
Physical activity counselling* 16.9 (15.8–17.9) 24.1 (22.4–25.8)
Cholesterol measurement (within previous year) 27.9 (26.7–29.2) 58.3 (55.9–60.6) 
Prevention delivery (at least one of the above-mentioned) 69.1 (68.1–70.0) 68.1 (66.6–69.6)
Medical consultation (within previous year) 75.3 (74.4–76.2) 81.5 (80.0–82.9)
*Usually during a medical consultation; CI — confidence interval
Table 2. Proportions of various types of medical practice in medical consultations (adjusted for age)
Type of medical practice WOBASZ — % (95% CI) WOBASZ II — % (95% CI)
Men
General practitioner’s practice 86.9 (86.1–87.7) 85.7 (84.3–87.1)
Specialist medical practice (public) 9.4 (8.7–10.1) 9.3 (8.1–10.5)
Specialist medical practice (private) 3.6 (3.2–4.1) 5.0 (4.2–5.8)
Women
General practitioner’s practice 86.5 (85.7–87.3) 84.6 (83.3–85.9)
Specialist medical practice (public) 8.9 (8.2–9.5) 10.1 (9.1–11.2)
Specialist medical practice (private) 4.7 (4.2–5.1) 5.2 (4.5–6.0)
CI — confidence interval
Table 3. Prevention support (*) by type of medical practice (adjusted for age)
Types of medical practices WOBASZ — % (95% CI) WOBASZ II — % (95% CI) p
Men
General practitioner’s practice 36.6 (35.4–37.8) 45.4 (43.4–47.5) < 0.0001
Specialist medical practice (public) 48.4 (44.6–52.1) 54.7 (48.3–61.2) NS
Specialist medical practice (private) 40.3 (34.5–46.1) 38.4 (29.9–46.9) NS
Women
General practitioner’s practice 35.3 (34.2–36.4) 41.3 (39.5–43.1) 0.0006
Specialist medical practice (public) 42.4 (38.8–46.0) 40.2 (34.7–45.7) NS
Specialist medical practice (private) 34.6 (29.8–39.3) 32.7 (25.2–40.1) NS
*Percentage of persons recalling at least two preventive consultations during a medical visit; CI — confidence interval; NS — not significant
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highest proportion of persons recalling at least two preventive 
consultations) was given by specialists from public medical 
practices. In both studies there were significant differences 
between the frequency of preventive consultations offered 
to men by GPs vs. public specialist practitioners. For women 
such differences were present only in the WOBASZ study 
(Table 3).
At least one piece of preventive advice during a medical 
consultation was offered to 68% of men and women in both 
studies (Table 1), which means that one-third of respondents 
did not receive any lifestyle modification advice or had their 
blood pressure and cholesterol concentration measured.
The most common element of CVD prevention was 
blood pressure measurement, which was performed during 
about 60% of medical visits in both study periods, followed 
by smoking cessation advice. Recommendation of increased 
physical activity was offered the least often. In the years 
2013–2014, compared to 2003–2005, the frequency of smok-
ing cessation and dietary advice, physical activity counselling, 
and cholesterol concentration measurements increased in 
men, while only the frequency of physical activity counsel-
ling and cholesterol concentration measurements increased 
in women (Table 1). Particular attention should be given to 
the more than twofold increase in cholesterol concentration 
measurements in 2013–2014 compared to 2003–2005. Even 
among subjects without any risk factors in WOBASZ II, more 
than 45% of participants had their cholesterol concentration 
measured during the previous year. In the WOBASZ study 
this rate ranged between 13% and 18% (Table 4). 
We can conclude that CVD diagnosis had a beneficial 
influence on the quality of medical care because lifestyle 
counselling as well as blood pressure and cholesterol meas-
urements were performed more frequently in participants 
from the secondary prevention group, compared to the 
primary prevention subjects and the persons without CVD 
risk factors (Table 4). The preventive support in the secondary 
prevention population did not differ between WOBASZ and 
WOBASZ II, except for the significant increase in frequency 
of cholesterol concentration measurements in WOBASZ II. 
There was no difference between the preventive support given 
to the persons with history of CVD hospitalisation compared 
to those who were not hospitalised but were diagnosed with 
CAD or had a history of stroke (data not shown in a table). 
However, in both study periods, about one-third of men and 
women with CAD or a history of stroke did not receive suf-
ficient preventive support. 
In WOBASZ II, compared to the previous study, pre-
ventive support in the primary prevention group improved 
in terms of the frequency of cholesterol concentration 
measurements as well as nutrition and physical activ-
ity counselling. However, recommendations regarding 
a healthy diet and increased physical activity were still 
given to too few patients (only to about a quarter of subjects 
visiting their physicians). 
A significant association between the quality of preventive 
support and age, health status and study period was con-
firmed. Participants who were offered two or more prevention 
consultations at a single medical visit were more often in the 
primary or secondary prevention group and were more often 
examined in the years 2013–2014 (WOBASZ II) rather than 
2003–2005 (WOBASZ) (Table 5).
DISCUSSION
Cardiovascular disease prevention was defined as a coor-
dinated set of actions at the individual or population level, 
which are aimed at eliminating or minimising the impact of 
CVD and its related disabilities [10]. According to the World 
Health Organization, 75% of CVD deaths were preventable 
by promoting changes in lifestyle towards risk-factor reduc-
tion. CVD prevention should be targeted both at individuals 
(especially those with a moderate or high CVD risk and CAD 
patients) and at the general population; moreover, it should 
be a long-term action. Prevention guidelines, published suc-
cessively in the years 1994, 1998, 2012, and 2016, recom-
mended smoking cessation, promoting free-time physical 
activity, a healthy diet, reduction of overweight and hyperten-
sion, maintaining the cholesterol concentration < 5 mmol/L, 
and avoiding stress [1]. In 2016 greater attention was paid to 
Table 5. The association between prevention support (*) and 
selected factors
ORPC (95% CI) p
Men
Age (∆ 1 year) 1.04 (1.03–1.04) < 0.001
Status: < 0.001
Without risk factors 1.0
Primary prevention 2.57 (2.08–3.17)
Secondary prevention 1.22 (1.11–1.34)
Study: < 0.001
WOBASZ 1.0
WOBASZ II 9.10 (7.04–11.78)
Women
Age (∆ 1 year) 1.04 (1.04–1.05) < 0.001
Status: < 0.001
Without risk factors 1.0
Primary prevention 2.13 (1.83–2.48)
Secondary prevention 4.96 (4.03–5.11)
Study: 0.0080
WOBASZ 1.0
WOBASZ II 1.13 (1.03–1.24)
*ORPC — odds ratio for at least two prevention consultations during  
a medical visit; CI — confidence interval
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the population-level approach, and there was more focus on 
young people, women, and particular diseases. 
Preventive counselling should be a part of each medical 
consultation because it was proven that behaviour interven-
tions, such as “pep talk,” increased the efficacy of prevention 
[11]. Such interventions are particularly recommended for 
high-risk persons [12–14]. Studies from 1990 to 1998 showed 
that preventive counselling was offered during 20% to 60% 
of medical visits [15, 16]. As was shown in the EUROASPIRE 
study, there was a discrepancy between preventive guidelines 
and clinical practice [6]. The main problem was related to 
the lack of time for such interventions. In clinical practice, 
preventive counselling was offered mainly to persons with 
diagnosed CVD. The results of an American study on physi-
cians’ perception of their role and the barriers in preventive 
action showed that primary prevention was not considered 
as a priority in relation to the rapid effects of the secondary 
prevention. The majority of physicians thought that preventive 
support was neither a major part of their job nor an effective 
utilisation of their work time, which, in their opinion, should 
instead be spent on the diagnosis and treatment of specific 
diseases. At the same time, they thought that preventive 
support should be turned over to nurses or dietitians [17]. 
Recently, a great deal of attention has been paid to projects 
coordinated by nurses [18, 19].
Experts from the Polish Cardiac Society initiated The Op-
timal Model of Comprehensive Rehabilitation and Secondary 
Prevention, a novel project aimed at the management of 
complex cardiac rehabilitation and secondary prevention 
in the whole of Poland [20]. It was shown that secondary 
prevention after acute coronary syndrome is an extremely 
important and cost-effective procedure.
The results of WOBASZ and WOBASZ II showed bet-
ter preventive action in the years 2013–2014 compared to 
2003–2005. Particularly good improvement was observed in 
the frequency of cholesterol concentration measurements. In 
the years 2013–2014 cholesterol measurements were con-
firmed by twice as many men and women than 10 years 
earlier. Lipid abnormalities were the most frequently observed 
and the worst controlled CVD risk factor in Poland [21, 22]. 
Screening tests for hyperlipidaemia should be common in the 
general population and should be performed in subjects with 
at least one CVD risk factor, i.e. arterial hypertension, smoking 
habit, diabetes, and overweight, as well as in subjects with 
CVD, chronic kidney disease, or autoimmune disorder, and 
additionally in men aged over 40 years and women aged over 
50 years. If the patient’s cholesterol concentration is within the 
normal range, the measurement should be done every three 
to five years, but in persons with hyperlipidaemia, it should 
be repeated every year after reaching the target values [23]. 
Recommendations regarding a healthy diet and increased 
physical activity were more often offered to patients in 
2013–2014 than 10 years earlier, but still it was not common 
enough. Moreover, there was a relationship between preven-
tive support and the health status defined as the lack or the 
presence of CVD risk factors (but excluding the subjects with 
CVD, CAD, or a history of stroke), showing better medical 
care in patients with poor health status.
Primary care physicians play the most important role in 
CVD prevention because two-thirds of the population visit their 
GPs at least once a year and 90% at least once in five years [24]. 
During one year Polish GPs had contact with about two-thirds of 
the Polish adult population (60% of men and 80% of women). In 
WOBASZ and WOBASZ II, at least one preventive counselling 
session was recalled by 68% of both men and women, so more 
than one-third of patients attending their physicians did not 
receive any preventive support, including about 20% of persons 
after myocardial infarction or stroke. The highest percentage 
of respondents without any preventive support (about 40%) 
were persons with no risk factors, even though these persons 
visit their GPs as often as other people. Even healthy subjects, 
irrespective of age, should lead a healthy lifestyle, so preventive 
consultations should be given to everyone. 
We found that not every patient visiting their GPs, dur-
ing both study periods, had their blood pressure measured, 
and the frequency of these measurements did not increase 
over time. As reported by the respondents of the WOBASZ 
studies, blood pressure measurement was made in about 60% 
of medical appointments and in more than 70% of CAD or 
stroke patients’ consultations. 
In a study evaluating the medical documents from four 
GP practices in the Mazowieckie voivodship, data on blood 
pressure were not present in 43% of cases, which means that 
almost 50% of patients did not have their blood pressure 
checked or it was not recorded [25].
Preventive action should involve popularisation of active 
lifestyle (at least 150 min of moderate or 75 min of vigorous 
aerobic physical activity per week in healthy persons). It is well 
known that physical activity plays an important role in the re-
duction of premature death risk and in the prevention of CVD, 
diabetes, cancer, depression, and many other diseases [26]. 
However, physical activity counselling is not frequent enough 
in the everyday physician’s practice. Despite the significant 
increase in the frequency of physical activity counselling be-
tween analysed studies (especially in the primary prevention 
group), we found that this type of advice was still given to too 
small a group of patients consulting their GPs (from about 10% 
of persons without risk factors to 30% of persons subjected to 
secondary prevention). In the American study, based on direct 
observation, advice on physical activity was offered during 
22.3% of medical consultations, and at the same time the rate 
reported by patients in a questionnaire was only 13% [25]. In 
our study such recommendations were given more often to 
men and persons with risk factors or chronic diseases [27]. In 
both studies discussed hereby, the percentage of respondents 
(from about one-fourth to one-fifth) who recalled physical ac-
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tivity consultations during a medical visit was much lower than 
in the EUROPREVIEW study (55%), a cross-sectional survey 
conducted in 2008–2009 in 22 European countries, covering 
primary care patients [28]. In the opinion of American GPs, 
the main problems related to giving such counselling were the 
lack of time, the lack of adequate knowledge to recommend 
particular types of exercise, and the lack of belief in the pos-
sibility of changing patients’ behaviour to a healthier level. 
A proper diet has a significant impact on health. A diet 
low in saturated fat, with a focus on wholegrain products, 
vegetables, fruit, and fish should be recommended [1]. In both 
WOBASZ studies, dietary consultations were not a frequent 
practice (25% to 30% of respondents recalled such recom-
mendations) and were given predominantly to persons with 
diagnosed CVD (about 40%–45% of cases). Similar results 
were obtained by Eaton et al. [29]; the dietary support was 
given during about 25% of outpatient visits and in about 30% 
of visits of patients suffering from chronic diseases. In the Polish 
data from the Cracovian Programme for Secondary Prevention 
of Ischaemic Heart Disease (the Polish part of EUROASPIRE), 
performed in five city hospitals and covering patients with 
myocardial infarction, dietary consultations, as declared by 
patients, were much more common and reached 71.2% for 
recommendations of increased fish intake and 84.0% for 
recommendations of reduced fat intake [30]. 
Thorndike et al. [31] showed, similarly as in WOBASZ 
and WOBASZ II, that about 70% of smokers visit their GP at 
least once a year, so outpatient clinics might be a perfect place 
for smoking cessation interventions. Even if physicians think 
that smoking cessation advice has a low priority among their 
patients, and that it is time-consuming and ineffective [32], 
patients anticipate such advice; e.g., 46.3% of primary care 
patients from the EUROPREVIEW study would like to receive 
advice regarding quitting smoking and 63.4% would like to 
discuss it with their GPs [28], and consider it as integral part 
of medical care [33]. In another American study, with physi-
cians and nurses as participants, 69% of physicians declared 
that they always or almost always recommended their patients 
to stop smoking [34]. In both studies discussed hereby the 
percentage of such advice was lower (about 50%); however, 
a different methodology of data collection was applied: in the 
American study it was physicians who answered a question-
naire (overestimated data), whereas in the WOBASZ studies 
the patients were the respondents (underestimated data). 
In both WOBASZ studies, the highest proportion (> 70%) 
of smokers who recalled having received smoking cessation 
advice during a single medical consultation were secondary 
prevention subjects. Considering only the population of per-
sons subjected to secondary prevention, and comparing our 
data with Cracovian EUROASPIRE data, the rates of persons 
recalling a smoking intervention were similar [30]. 
In conclusion, the results of the Multi-centre National 
Population Health Examination Surveys (WOBASZ and 
WOBASZ II) showed better prevention support in the years 
2013–2014 compared to 2003–2005; however, it was still in-
sufficient in terms of the frequency of prevention recommen-
dations. About one-third of persons visiting physicians did not 
receive any preventive counselling. The prevention support 
was offered more often to patients with worse health status. 
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